Results 171 to 180 of about 270,350 (354)

An unusual ST-segment elevation: Apical hypertrophic cardiomyopathy shows the ace up its sleeve

open access: yesRevista Portuguesa de Cardiologia, 2013
Apical hypertrophic cardiomyopathy is part of the broad clinical and morphologic spectrum of hypertrophic cardiomyopathy. We report a patient with electrocardiographic abnormalities in whom acute coronary syndrome was excluded and apical hypertrophic ...
Francesco de Santis   +5 more
doaj  

Difference in the response to isoproterenol between asymmetric septal hypertrophy and symmetric hypertrophy in patients with hypertrophic cardiomyopathy [PDF]

open access: bronze, 1986
Keiji Iida   +8 more
openalex   +1 more source

Clinical Phenotype and Neuroimaging Findings in Siblings with COX15 Deficiency: Case Report and Review of Previously Reported Cases

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Haya S. AlFaris   +8 more
wiley   +1 more source

Functional Movement Disorder in Familial Ataxia: A Case Report of Monozygotic Twins

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Daniela Kern   +2 more
wiley   +1 more source

Matrix metalloproteinase inhibition protects against junctophilin‐2 proteolysis during doxorubicin‐induced cardiotoxicity

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Treatment of cancer patients with anthracyclines is known to cause dose‐dependent cardiotoxicity through several mechanisms including enhanced oxidative stress, ultimately resulting in defective excitation–contraction coupling.
Wesam Bassiouni   +9 more
wiley   +1 more source

Myosin inhibitors for treatment of hypertrophic cardiomyopathy. [PDF]

open access: yesCochrane Database Syst Rev
Quill S   +6 more
europepmc   +1 more source

Polypharmacy in mice disrupts left ventricular function and structure and promotes proteome reorganisation in an age‐ and sex‐specific fashion

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Most older people use polypharmacy (≥5 medications), particularly those with cardiovascular disease. The effects of polypharmacy on the cardiovascular system are not well described. We examined the effect of a chronic polypharmacy regimen on left ventricular (LV) function, structure and proteome in young and old mice of both ...
Trang Tran   +9 more
wiley   +1 more source

Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes

open access: yesNature Communications, 2022
Bradley A. Maron   +14 more
doaj   +1 more source

Dexrazoxane protects against doxorubicin‐induced cardiotoxicity in susceptible human living myocardial slices: A proof‐of‐concept study

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose The increasing number of cancer survivors has caused growing concern over chemotherapy‐induced cardiotoxicity. This study aimed to investigate a novel human model of cardiotoxicity and explore cardioprotection. Experimental Approach Living myocardial slices (LMS) were obtained from explanted end‐stage heart failure ...
Jort S. A. van der Geest   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy